Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia

Journal of Medical Screening

Volumn 4, Issue 1, 1997, Pages 40-43

  Stockton, Diane ^a,b   Cooper, Pauline ^a,c   Lonsdale, R N ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Cervical cancer; Incidence

Indexed keywords

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 0031399579     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1177/096914139700400112     Document Type: Article

References (17)

1. Davis JR, Moon LB. Increased incidence of adenocarcinoma of uterine cervix. Obstet Gynecol 1975;45:79-83.
2. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
3. Kjaer SK, Brinton LA. Adenocarcinoma of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486-97.
4. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of the cervix uteri. Obstet Gynecol 1995;85:1017-20.
5. 4a European Network of Cancer Registries. EUROCIM user manual, 2nd ed. Lyon: International Agency for Research on Cancer, 1995.
6. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 1985;92:150-7.
7. Anderson GH, Boyes DA, Benedet JL, et al. Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85. BMJ 1988;296:975-8.
8. Bj0rge T, Thoresen S0, Skare GB. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990. Eur J Cancer 1993;29A:2291-7.
9. Wijngaarden WJ Van, Duncan ID, Hussain KA. Screening for cervical neoplasia in Dundee and Angus: 10 years on. BrJ Obstet Gynaecol 1995;102:137-42.
10. Peters RK, Chao A, Mack TM, et ai Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-8.
11. Ursin G, Pike MC, Preston-Martin S, dAblaing III G, Peters RK. Sexual, reproductive and other risk factors for adenocarcinoma of the cervix: results from a populationbased case-control study (California, United States). Cancer Causes Control 1996;7:391-401.
12. Dallenbach-Hellweg G. On the origin and histological structure of adenocarcinoma of the endocervix in women under 50 years of age. Palhol Res Pract 1984;179:38-50.
13. Jones MW, Silverberg SG. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol 1989;73:984-9.
14. Maier RC, Morris HJ. Coexistence of cervical intra epithelial neoplasia with primary adenocarcinoma of the endocervix. Obstet Gynecol 1980;56:361-4.
15. Schwartz SM, Weiss NS. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 1986;124:1045-8.
16. Chilvers C, Mant D, Pike MC. Cervical adenocarcinoma and oral contraceptives. BMJ 1987;295:1446-7.
17. Crowther ME. Is the nature of cervical carcinoma changing in young women? Obstet Gynecol Surv 1994;50:71-82.